Literature DB >> 8957089

Genomic organization of the human NTRK1 gene.

A Greco1, R Villa, M A Pierotti.   

Abstract

The NTRK1 gene encodes one of the receptors for the Nerve Growth Factors and it is located at 1q21-22. Rearrangements of NTRK1 are frequently detected in human papillary thyroid carcinoma and lead to the formation of chimeric oncogenes, similarly to what observed for the other neurotrophin receptor RET. In addition, the two receptor genes are target of point mutations associated with different human diseases. RET is affected by germ line and somatic mutations in MEN2A, MEN2B tumor syndromes and in the abnormal developmental Hirschsprung disease, whereas mutations of NTRK1 have been reported very recently in patients with congenital insensitivity to pain with anidrosis (CIPA). With the aim to provide a tool for searching mutations along the whole NTRK1 gene, we have determined its genomic organization. Our results demonstrated that NTRK1 is contained within 25 Kb of DNA and is organized in 17 exons, one of which is alternatively spliced. The sequence of the 5' flanking region indicates a high content in C/G, the absence of TATA box, the presence of several putative binding sites for Sp1, AP1, AP2, AP3, ATF and GCF transcription factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957089

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  DNA copy number changes in Schistosoma-associated and non-Schistosoma-associated bladder cancer.

Authors:  W El-Rifai; D Kamel; M L Larramendy; S Shoman; Y Gad; S Baithun; M El-Awady; S Eissa; H Khaled; S Soloneski; M Sheaff; S Knuutila
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 2.  Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.

Authors:  Subrata Pramanik; Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

3.  Role of neurotrophins and neurotrophins receptors in the in vitro invasion and heparanase production of human prostate cancer cells.

Authors:  E T Walch; D Marchetti
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

4.  Molecular basis for keratoconus: lack of TrkA expression and its transcriptional repression by Sp3.

Authors:  Alessandro Lambiase; Daniela Merlo; Cristiana Mollinari; Paolo Bonini; Anna Maria Rinaldi; Mauro D' Amato; Alessandra Micera; Marco Coassin; Paolo Rama; Stefano Bonini; Enrico Garaci
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

Review 5.  Molecular genetics of hereditary sensory neuropathies.

Authors:  Michaela Auer-Grumbach; Barbara Mauko; Piet Auer-Grumbach; Thomas R Pieber
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

6.  Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor.

Authors:  S Mardy; Y Miura; F Endo; I Matsuda; L Sztriha; P Frossard; A Moosa; E A Ismail; A Macaya; G Andria; E Toscano; W Gibson; G E Graham; Y Indo
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

7.  Anti-apoptotic effect of nerve growth factor is lost in congenital insensitivity to pain with anhidrosis (CIPA) B lymphocytes.

Authors:  Yuya Sato; Yayoi Tsuboi; Hidemitsu Kurosawa; Kenichi Sugita; Mitsuoki Eguchi
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

Review 8.  Exploring Missense Mutations in Tyrosine Kinases Implicated with Neurodegeneration.

Authors:  Neha Sami; Vijay Kumar; Asimul Islam; Sher Ali; Faizan Ahmad; Imtaiyaz Hassan
Journal:  Mol Neurobiol       Date:  2016-08-20       Impact factor: 5.590

9.  Novel NTRK1 mutations cause hereditary sensory and autonomic neuropathy type IV: demonstration of a founder mutation in the Turkish population.

Authors:  Beyhan Tüysüz; Fatih Bayrakli; Michael L DiLuna; Kaya Bilguvar; Yasar Bayri; Cengiz Yalcinkaya; Aysegul Bursali; Elif Ozdamar; Baris Korkmaz; Christopher E Mason; Ali K Ozturk; Richard P Lifton; Matthew W State; Murat Gunel
Journal:  Neurogenetics       Date:  2008-03-06       Impact factor: 2.660

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.